SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as Novo Nordisk's lawsuit and increased regulatory scrutiny over its compounded GLP-1 weight-loss medications have led the company to halt sales of its unapproved pill; this has polarized community sentiment, with bulls anticipating a bounce and bears predicting further declines due to legal risks.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending following a $250 million capital commitment designed to extend its operational runway through 2028, sparking intense community debate between those who see it as a strong foundation for its traceability technology and critics wary of past dilution and extreme volatility.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies ($PGY) is trending amidst sharp post-earnings volatility, as a slight revenue miss and cautious guidance overshadow its continued profitability and new forward flow agreement, driving a fierce debate among investors who see an extreme overreaction and a significant buying opportunity against those concerned about broader fintech weakness and ongoing share price manipulation.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending following its Q4 earnings, where an EPS beat was overshadowed by a revenue miss, though management's optimistic 2026 guidance for improved steel prices and a value-accretive expiring slab contract is fueling discussion. The community is highly focused on the anticipated strategic partnership with POSCO and whether this, combined with favorable trade policies, will finally drive a significant turnaround for the steel producer.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is buzzing with renewed investor interest following Tether's substantial financial commitments and the Northern Data acquisition, which is set to boost its AI and cloud infrastructure. The community is eagerly anticipating a short squeeze, citing record-high short interest and Tether's strategic backing as key catalysts for growth.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com (MNDY) is trending sharply lower after providing a weaker-than-expected revenue outlook, despite beating Q4 earnings and revenue estimates. The community is actively debating whether this sell-off is an overreaction or a legitimate concern that AI advancements pose a significant threat to its business model.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is drawing significant community attention following a popular YouTube video showcasing its Eagle Line pilot production, igniting speculation on solid-state battery commercialization and potential OEM partnerships. Many anticipate key updates surrounding its upcoming earnings, while others express frustration over continued delays and the absence of firm revenue.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean's all-stock agreement to acquire Valaris aims to create an offshore drilling industry leader poised for an emerging upcycle, sparking community debate over whether this strategic consolidation will reduce debt and ignite a short squeeze despite the immediate negative stock reaction.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl is experiencing an extreme sell-off and trading halts after cutting its earnings outlook and announcing leadership changes including its CFO and general counsel amid a financial reporting review, fueling community speculation around financial improprieties. While many fear further declines, other investors are actively discussing the steep drop as an overreaction and a potential 'buy the dip' opportunity for the IT services firm.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending after Morgan Stanley initiated coverage with an "Overweight" rating and a substantial price target, validating its strategy to convert Bitcoin mining infrastructure into high-performance computing data centers. The community is actively discussing the potential for a short squeeze and the company's strong position to capitalize on increasing AI infrastructure spending by hyperscalers, despite some ongoing volatility and perceived correlation to Bitcoin.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GH Research PLC (NASDAQ:GHRS) Receives Consensus Rating of "Moderate Buy" from Analysts

GH Research PLC (NASDAQ:GHRS - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twelve ratings firms that are presently covering the stock, MarketBeat.com reports. One...

GH Research (NASDAQ:GHRS) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Royal Bank Of Canada lifted their price target on GH Research from $33.00 to $40.00 and gave the stock an "outperform" rating in a research report on Friday...

GH Research (NASDAQ:GHRS) Stock Price Down 7.5% - Here's What Happened

GH Research (NASDAQ:GHRS) Stock Price Down 7.5% - Should You Sell...

GH Research (NASDAQ:GHRS) Stock Price Down 9.2% - Should You Sell?

GH Research (NASDAQ:GHRS) Stock Price Down 9.2% - Should You Sell...

GH Research (NASDAQ:GHRS) Shares Gap Up - Time to Buy?

GH Research (NASDAQ:GHRS) Shares Gap Up - Should You Buy...

Altimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday

FDA Lifts Hold On GH Research's Depression Drug Trial After Two Years

The FDA lifted its clinical hold on GH Research's GH001 after Phase 2b data showed rapid, durable benefits in treatment-resistant depression, clearing the path toward Phase 3 trials planned for...

<ul class="summary-bullets"><li>The company is targeting the initiation of Phase 3 clinical trials this year.</li><li>In an update about the GH001 Phase 2b clinical trial, GH Research stated that the primary endpoint was met with a highly significant placebo-adjusted reduction from baseline.</li><li>It added that there were no treatment-related serious adverse events during the six-month trial duration.</li></ul>GH Research PLC (GHRS) shares gained more than 42% in Monday’s opening session after the company announced a positive development in its depression treatment trials.GH Research announced on Monday that the U.S. Food and Drug Administration (FDA) had lifted the clinical hold on GH001, its lead product candidate.<h2 class="st-heading-2">FDA Lifts Hold</h2>In a filing with the U.S. Securities and Exchange Commission (SEC), GH Research stated that the FDA has cleared GH001 for a clinical investigation in the United States, subject to the enrollment of participants. The company is targeting the initiation of Phase 3 clinical trials this year.“We continue to expect initiation of our global pivotal program in 2026. We look forward to meeting with the FDA to align on the design for the pivotal Phase 3 program,” said GH Research CEO Dr. Velichka Valcheva.GH Research is a Dublin, Ireland-based clinical-stage biopharmaceutical company, focusing on the development of proprietary mebufotenin therapies for the treatment of patients with treatment-resistant depression (TRD).<h2 class="st-heading-2">GH001 Phase 2b Data</h2>In an update about the GH001 Phase 2b clinical trial, GH Research stated that the primary endpoint was met with a highly significant placebo-adjusted reduction from baseline.The company stated that a full analysis of the open-label extension (OLE) phase showed a 73% remission rate at six months with infrequent treatment visits and no mandated psychotherapeutic intervention.Further, the company said that a safety analysis showed 100% of the patients from the double-blind (DB) part continued in the OLE. It added that there were no treatment-related serious adverse events during the six-month duration of the trial.OLE is a phase of clinical trials in which participants may continue receiving the experimental treatment after completing the initial controlled phase.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits regarding&nbsp;<a href="https://stocktwits.com/symbol/GHRS">GH Research</a> trended in the ‘extremely bullish’ territory at the time of writing.&nbsp;One Stocktwits user expects GHRS stock to rally further when the markets open.<stembedurl>https://stocktwits.com/BLD33/message/640804183</stembedurl><a href="https://stocktwits.com/symbol/GHRS">GHRS stock</a> is up 48% year-to-date and 108% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-dvlt-stock-gaining-today/cmxMnTMR4bM">Why Is DVLT Stock Gaining Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the GH Research logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Why Is GHRS Stock Rising Today?

GH Research stated that the FDA has cleared GH001 for a clinical investigation in the U.S.

Equity

GH Research (NASDAQ:GHRS) Receives Buy Rating from Needham & Company LLC

Needham & Company LLC reiterated a "buy" rating and set a $19.00 price objective on shares of GH Research in a research note on Monday...

NextEra Energy, GH Research And 3 Stocks To Watch Heading Into Monday

GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.

GHRS
GH Research PLC

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GHRS News

GHRSGH Research PLC